Wholesalers Are Key To Safety Of Any Rx Importation Plan, HDMA Tells Task Force
This article was originally published in The Pink Sheet Daily
Executive Summary
Healthcare Distribution Management Association is "very comfortable" with a wholesaler-implemented "closed" importation system, the trade group tells HHS' import task force. However, any import plan still needs to address obstacles including costs of relabeling and authority to recall products.
You may also be interested in...
Rx Importation Would Require Increased Wholesaler Regulation, PhRMA Says
PhRMA Assistant General Counsel Lassman says a commercial drug importation program would be unsafe until wholesalers are “adequately” regulated. Certain states are strengthening wholesaler regulation, but the problem is “not solved by any means right now,” Lassman says.
Rx Importation Would Require Increased Wholesaler Regulation, PhRMA Says
PhRMA Assistant General Counsel Lassman says a commercial drug importation program would be unsafe until wholesalers are “adequately” regulated. Certain states are strengthening wholesaler regulation, but the problem is “not solved by any means right now,” Lassman says.
HDMA Sees Reimportation In 2005 Regardless Of Presidential Election Results
Rx importation will "come to pass one way or another," Healthcare Distribution Management Association CEO John Gray says. An association-commissioned report is designed to demonstrate the value of distributors in the pharmaceutical supply chain.